Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Vaccines
Filter     Order     Display # 
Date Item Title
01 Jul 2008 IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP)
30 Jun 2008 Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N1) Vaccine
30 Jun 2008 GlaxoSmithKline responds to FDA on Cervarix(R) and plans to submit final study data for approval
29 Jun 2008 Greer Completes Enrollment for Pivotal Phase III Clinical Trial Evaluating the Efficacy of Sublingual-Oral Immunotherapy for Treating Short Ragweed Allergies
25 Jun 2008 Medicago's H5N1 VLP Vaccine Demonstrates Cross-Reactivity Against Multiple Strains of Avian Flu in Key Ferret Animal Model
19 Jun 2008 Bavarian Nordic reports interim data from Phase I/II studies with breast cancer vaccine
18 Jun 2008 Nventa Develops Proprietary Vaccine adjuvant
17 Jun 2008 CSL Receives TGA Approval to Register Panvax(R), Avian Flu Vaccine
16 Jun 2008 Vical Pandemic Influenza Vaccines Provide Complete Protection in Animal Studies; The Journal of Infectious Diseases Publishes H5N1 Challenge Data
12 Jun 2008 Opexa Therapeutics Reports Favorable Two-Year Data in Phase I/II Retreatment Studies of Tovaxin(R) for Multiple Sclerosis
12 Jun 2008 Promising Data Presented on Genvec Malaria Vaccine Program
12 Jun 2008 Phase III data show GSK paediatric candidate vaccine’s potential to provide improved protection against life-threatening pneumococcal diseases
08 Jun 2008 Emergent BioSolutions Initiates U.S. Phase II Trial of Oral Typhoid Vaccine Candidate
04 Jun 2008 NIH Initiates Phase 1 Safety Study of AVANT's Oral Combined Enterotoxigenic E. coli-Cholera Vaccine
04 Jun 2008 Reduced Hepatitis C Viral Level Achieved with DNA Vaccine Delivered by Inovio Biomedical's Electroporation Delivery System in Phase I/II Clinical Study
04 Jun 2008 Novartis presents full pipeline of novel vaccines addressing significant unmet needs
04 Jun 2008 Bavarian Nordic enters clinical trials with prostate cancer vaccine
03 Jun 2008 Sanofi-Aventis and Oxford Biomedica report encouraging Trovax(R) phase II trial results in Metastatic Renal Cancer
03 Jun 2008 Updated CDX-110 Data in Glioblastoma Multiforme Presented at 44th Annual ASCO Annual Meeting
03 Jun 2008 Transgene's Therapeutic Vaccine TG4010 Meets Primary Endpoint in Non-Small Cell Lung Cancer Phase IIb Trial
03 Jun 2008 Hemispherx Biopharma Press Release for
03 Jun 2008 IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients
03 Jun 2008 Stimuvax Phase 1/2 survival data support prior results
03 Jun 2008 Cell Genesys Reports Updated Results From Phase 1 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Used in Combination With Ipilimumab
30 May 2008 New data on MAGE-A3 cancer immuno therapy support novel options of treating non-small cell lung cancer and melanoma
29 May 2008 Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers
28 May 2008 Juvaris BioTherapeutics Initiates Phase I Clinical Trial of JVRS-100 Adjuvnated Seasonal Influenza Vaccine
28 May 2008 Bharat Biotech Announces Successful Completion Of Its Phase I/II Clinical Trial For 116E Rotavirus Vaccine
27 May 2008 Favrille Announces Results from Phase 3 Registration Trial of Specifid in Patients with Follicular B-Cell Non-Hodgkin's Lymphoma
27 May 2008 Bavarian Nordic enters clinical trials with HIV multiantigen vaccine
19 May 2008 First pre-pandemic vaccine approved to help protect against pandemic influenza
16 May 2008 Dynavax TOLAMBA(TM) Chamber Study Misses Primary Endpoint; Company Updates 2008 Financial Outlook
15 May 2008 Novavax completes enrollment in phase 1/IIa pandemic influenza vaccine clinical trial
14 May 2008 In a Phase II study, Novartis Meningitis B vaccine has potential to produce a protective immune response in infants[1], the age group most at risk
12 May 2008 Nventa announces additional positive immunological data from HSPE7 phase 1 Cervical Dysplasia trial
09 May 2008 Dutch Authorize Manufacture of Vaccinogen’s New Cancer Vaccine
06 May 2008 Novartis Menveo(R) vaccine shows superior immune response against four types of meningitis disease in pivotal phase III trial
29 Apr 2008 Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
29 Apr 2008 DOR BioPharma Initiates Non-Human Primate Efficacy Studies of RiVaxTM, Its Vaccine Against Ricin Toxin
22 Apr 2008 Biovex agrees SPA with the FDA for a pivotal study with ONCOVEXGM-CSF in metastatic melanoma and announces presentation of phase II results at ASCO
17 Apr 2008 Alphavax announces initial analysis of data from CMV phase I clinical trial
17 Apr 2008 Dynavax and Merck & Co., Inc. Update Status of Clinical Hold of Investigational Vaccine HEPLISAV(TM)
16 Apr 2008 Pfizer and AVANT Enter into Licensing and Development Agreement for Novel Therapeutic Vaccine Candidate for Brain Cancer
16 Apr 2008 Novavax Reports Positive Results from Preclinical Studies of its VLP-based
15 Apr 2008 Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch
14 Apr 2008 Cell Genesys Reports Preclinical Data Demonstrating Superior Anti-Tumor Immunity for Multiantigen Compared to Single-Antigen Immunotherapies
11 Apr 2008 Cell Genesys Announces Encouraging Results from Phase 1/2 Trial of GVAX Immunotherapy for Prostate Cancer in Recurrent Disease
10 Apr 2008 Post-exposure vaccination with IMVAMUNE(R) protects against lethal poxvirus infection
09 Apr 2008 Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
08 Apr 2008 Oncophage(R) Approved in Russia for the Treatment of Intermediate-Risk Kidney Cancer
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 1 - 50 of 574

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Integrin Antagonists

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonistgs & Antagonists

Order Now

Subscribe La Merie Biologics